Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Hypersensitivity Reaction

  Free Subscription

Articles published in Pediatr Dermatol

Retrieve available abstracts of 105 articles:
HTML format

Single Articles

    February 2024
  1. SHAH MK, Barve A, Vasani R, Jadhav R, et al
    Bleach suit for atopic dermatitis.
    Pediatr Dermatol. 2024 Feb 12. doi: 10.1111/pde.15561.
    PubMed     Abstract available

  2. SIEGFRIED EC, Wine Lee L, Spergel JM, Prescilla R, et al
    A case series of live attenuated vaccine administration in dupilumab-treated children with atopic dermatitis.
    Pediatr Dermatol. 2024 Feb 2. doi: 10.1111/pde.15518.
    PubMed     Abstract available

  3. KIM EJ, Hlobik M, Ho T
    Effectiveness of dupilumab in pediatric patients with a nummular phenotype of atopic dermatitis.
    Pediatr Dermatol. 2024 Feb 1. doi: 10.1111/pde.15541.
    PubMed     Abstract available

    January 2024
  4. TRACY A, Loop L, Bhatti S, Anterasian C, et al
    Multidisciplinary atopic dermatitis program: A novel approach to managing difficult-to-control atopic dermatitis patients.
    Pediatr Dermatol. 2024 Jan 17. doi: 10.1111/pde.15533.
    PubMed     Abstract available

  5. REDDY P, Mahajan R, Mehta H, De D, et al
    Increased prevalence of metabolic syndrome and non-alcoholic fatty liver disease in children with atopic dermatitis: A case-control study from northern India.
    Pediatr Dermatol. 2024 Jan 2. doi: 10.1111/pde.15502.
    PubMed     Abstract available

    Dupilumab: Two sides of a side-effect.
    Pediatr Dermatol. 2024;41:180-181.
    PubMed     Abstract available

  7. SPENCER RK, Bartholomew E, Padniewski J, Bhutani T, et al
    Current practices for pediatric phototherapy: Findings from a cross-sectional study.
    Pediatr Dermatol. 2024;41:66-69.
    PubMed     Abstract available

  8. REINHART JP, Kumar AB, Casanegra AI, Rooke TW, et al
    Bridging the gap in BASCULE syndrome: A retrospective case series of a recently described clinical entity.
    Pediatr Dermatol. 2024;41:46-50.
    PubMed     Abstract available

  9. SHEA M, Weese K, Dhossche J
    Leukemoid reaction in minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: A brief report.
    Pediatr Dermatol. 2024;41:141-142.
    PubMed     Abstract available

  10. ALZAHRANI F, Miller HK, Sacco K, Dupuy E, et al
    Severe eczema in Wiskott-Aldrich syndrome-related disorder successfully treated with dupilumab.
    Pediatr Dermatol. 2024;41:143-144.
    PubMed     Abstract available

  11. SANFILIPPO E, Habeshian K, Cotton CH, Kirkorian AY, et al
    Severe reactive infectious mucocutaneous eruption mimicking drug-induced epidermal necrolysis triggered by norovirus.
    Pediatr Dermatol. 2024;41:84-86.
    PubMed     Abstract available

    November 2023
  12. KOUWENHOVEN TA, van Muijen ME, van de Kerkhof PCM, de Jong EMGJ, et al
    Effectiveness of systemic treatments on pruritus associated with atopic dermatitis: A systematic review in pediatric patients.
    Pediatr Dermatol. 2023 Nov 28. doi: 10.1111/pde.15468.
    PubMed     Abstract available

  13. LARSON JH, Heinlein J, Morris C, Ramsey K, et al
    Frequency of newborn bathing in the first 9 weeks of life and related factors: An observational study in a community-based sample from Meta-LARC.
    Pediatr Dermatol. 2023;40:1042-1048.
    PubMed     Abstract available

  14. ZEMLOK SK, Bentivegna K, Torre K, Rothe M, et al
    Perceptions of skincare ingredients and product labels in pediatric eczema care.
    Pediatr Dermatol. 2023;40:1068-1070.
    PubMed     Abstract available

  15. MILLER AE, Zhang D, Shields BE, Borghesi A, et al
    COVID-19 associated severe mucocutaneous blistering eruptions: A case series.
    Pediatr Dermatol. 2023;40:990-995.
    PubMed     Abstract available

  16. PAREEK S, Mohta A, Ghiya BC, Kumar Y, et al
    Concurrent acute generalized exanthematous pustulosis in siblings.
    Pediatr Dermatol. 2023;40:1101-1103.
    PubMed     Abstract available

  17. LIU S, Rodrigues M
    A cross-sectional study of pediatric dermatoses in a specialized pigment and skin-of-color center in Australia.
    Pediatr Dermatol. 2023;40:1074-1076.
    PubMed     Abstract available

    October 2023
  18. MARTINEZ-CABRIALES S, Marcoux D, Liy-Wong C, Prajapati VH, et al
    Multicenter Canadian case series of pediatric patients less than 12 years of age with moderate-to-severe atopic dermatitis treated with dupilumab.
    Pediatr Dermatol. 2023 Oct 31. doi: 10.1111/pde.15418.
    PubMed     Abstract available

  19. GUALDI G, Lougaris V, Amerio P, Petruzzellis A, et al
    Prurigo-like atopic dermatitis in a child with CARD11-associated severe combined immunodeficiency successfully treated with dupilumab.
    Pediatr Dermatol. 2023 Oct 27. doi: 10.1111/pde.15453.
    PubMed     Abstract available

  20. REIMER-TASCHENBRECKER A, Daniel M, Rangel SM, Paller AS, et al
    Do socioeconomic factors impact atopic dermatitis outcome? A single-center study.
    Pediatr Dermatol. 2023 Oct 10. doi: 10.1111/pde.15455.
    PubMed     Abstract available

    September 2023
  21. NETRAVALI IA, Sockler PG, Heimall J, Treat JR, et al
    Rapid resolution of diffuse warts following initiation of dupilumab for severe atopic dermatitis.
    Pediatr Dermatol. 2023 Sep 8. doi: 10.1111/pde.15414.
    PubMed     Abstract available

  22. RADTKE S, Grossberg AL, Wan J
    Mental health comorbidity in youth with atopic dermatitis: A narrative review of possible mechanisms.
    Pediatr Dermatol. 2023 Sep 4. doi: 10.1111/pde.15410.
    PubMed     Abstract available

    August 2023
  23. OHYA Y, Saeki H, Nawata H, Arima K, et al
    The disease burden of pediatric patients with atopic dermatitis in Japan.
    Pediatr Dermatol. 2023 Aug 15. doi: 10.1111/pde.15399.
    PubMed     Abstract available

  24. XU Y, Guo L, Li Z, Wu S, et al
    Efficacy and safety profile of dupilumab for the treatment of atopic dermatitis in children and adolescents: A systematic review and meta-analysis.
    Pediatr Dermatol. 2023 Aug 2. doi: 10.1111/pde.15398.
    PubMed     Abstract available

    July 2023
  25. DHIR B, Meena SK, Sardana K, Sharath S, et al
    Use of tofacitinib in baricitinib-refractory atopic dermatitis: An example of JAK inhibitor switching.
    Pediatr Dermatol. 2023 Jul 26. doi: 10.1111/pde.15386.
    PubMed     Abstract available

  26. MENDIRATTA V, Meena AK
    Clinical and epidemiological profile of lichen striatus in children-Experience from a tertiary care hospital.
    Pediatr Dermatol. 2023;40:642-643.
    PubMed     Abstract available

  27. JUNG EH, Avila SA, Nastasi S, Kim HJ, et al
    Immunoglobulin A vasculitis presenting as bilateral upper eyelid erythema: A case report and review of literature.
    Pediatr Dermatol. 2023;40:733-734.
    PubMed     Abstract available

    June 2023
  28. UDKOFF J, Borok J, Vaida F, Tang B, et al
    Assessment of the American Academy of Dermatology diagnostic criteria for pediatric atopic dermatitis and modification into a checkbox form: A cross-sectional study.
    Pediatr Dermatol. 2023 Jun 21. doi: 10.1111/pde.15338.
    PubMed     Abstract available

  29. GUPTA S, Ramam M, Sharma VK, Sethuraman G, et al
    Evaluation of a paraffin-based moisturizer compared to a ceramide-based moisturizer in children with atopic dermatitis: A double-blind, randomized controlled trial.
    Pediatr Dermatol. 2023 Jun 3. doi: 10.1111/pde.15355.
    PubMed     Abstract available

    May 2023
  30. HE C, Ci C, Lu X, Wang J, et al
    Erythematous papules and plaques on the extensor limbs of a healthy child.
    Pediatr Dermatol. 2023;40:556-558.

  31. WANG S, Berry CT, Treat JR, Jen M, et al
    Morphea after initiation of dupilumab in two pediatric atopic dermatitis patients.
    Pediatr Dermatol. 2023;40:540-543.
    PubMed     Abstract available

  32. NICKLES MA, Coale AT, Henderson WJA, Brown KE, et al
    Steroid phobia on social media platforms.
    Pediatr Dermatol. 2023;40:479-482.
    PubMed     Abstract available

  33. AKAMATSU M, Kawamura Y, Miura H, Sugimoto E, et al
    Systemic herpes simplex virus infection in a child with eczema herpeticum.
    Pediatr Dermatol. 2023;40:582-583.
    PubMed     Abstract available

  34. FITZGERALD LA, Drissi M, Sepulveda K, Hovland C, et al
    Presentation of cryopyrin-associated periodic fever syndrome as chronic, afebrile urticaria in a 12-month-old female.
    Pediatr Dermatol. 2023;40:532-533.
    PubMed     Abstract available

  35. BRENT G, Abdul-Wahab A, Borman AM, Ferguson L, et al
    Disseminated Bisifusarium infection following toxic epidermal necrolysis in a child with B-cell acute lymphoblastic leukemia.
    Pediatr Dermatol. 2023;40:503-506.
    PubMed     Abstract available

    April 2023
  36. POLASKEY MT, Bendelow A, Mukherji J, Buranosky B, et al
    Facial atopic dermatitis is associated with sensitization to cow's milk, egg whites, and peanuts in children under 36 months.
    Pediatr Dermatol. 2023 Apr 10. doi: 10.1111/pde.15326.
    PubMed     Abstract available

  37. O'CONNOR C, McCarthy S, Murphy M
    Pooling the evidence: A review of swimming and atopic dermatitis.
    Pediatr Dermatol. 2023 Apr 7. doi: 10.1111/pde.15325.
    PubMed     Abstract available

    March 2023
  38. GUI M, Johansen M, Reeder M
    An uncommon cause of swimmer's rash: Allergic contact dermatitis to persulfates in pools.
    Pediatr Dermatol. 2023 Mar 19. doi: 10.1111/pde.15293.
    PubMed     Abstract available

  39. ROWE G, Young GJ, Luu M
    Sources of online information utilized by caregivers of pediatric patients with atopic dermatitis.
    Pediatr Dermatol. 2023 Mar 3. doi: 10.1111/pde.15267.
    PubMed     Abstract available

  40. PHONG CH, Birmingham SW, Lee BA, Rojek NW, et al
    A case of eruptive lichen spinulosus after toxic epidermal necrolysis.
    Pediatr Dermatol. 2023;40:398-400.
    PubMed     Abstract available

  41. MCKINNON AT, Shalin SC, Evans MS
    Bilateral eyelid swelling as the presenting sign of subcutaneous sarcoidosis.
    Pediatr Dermatol. 2023;40:392-393.
    PubMed     Abstract available

  42. KRANYAK A, Shuler M, Williams KW, Wine Lee L, et al
    Case report of severe refractory inflammatory dermatoses in a young female diagnosed with hereditary alpha tryptasemia.
    Pediatr Dermatol. 2023;40:337-340.
    PubMed     Abstract available

    February 2023
  43. YU K, Seegan P, Lattanzio K, Chang H, et al
    Cognitive functioning in children with atopic dermatitis: Pilot observations.
    Pediatr Dermatol. 2023 Feb 27. doi: 10.1111/pde.15287.
    PubMed     Abstract available

  44. STEELE MV, Gupta R, Maguiness S, Boull C, et al
    Use of dupilumab for atopic dermatitis in young transplant patients-A case series of 3 patients.
    Pediatr Dermatol. 2023 Feb 23. doi: 10.1111/pde.15280.
    PubMed     Abstract available

    January 2023
  45. AHMED F, Takeshita J, Wan J
    Differences in prescriptions for systemic medications and nonsteroidal topicals among children with atopic dermatitis.
    Pediatr Dermatol. 2023 Jan 31. doi: 10.1111/pde.15263.
    PubMed     Abstract available

  46. ATWAL S, Ong PY
    Elevated serum total IgE is associated with eczema exacerbation in children hospitalized for atopic dermatitis.
    Pediatr Dermatol. 2023 Jan 19. doi: 10.1111/pde.15245.
    PubMed     Abstract available

  47. TANGTHANAPALAKUL A, Chantawarangul K, Wananukul S, Tempark T, et al
    Topical corticosteroid phobia in adolescents with eczema and caregivers of children and adolescents with eczema: A cross-sectional survey.
    Pediatr Dermatol. 2023;40:135-138.
    PubMed     Abstract available

    December 2022
  48. KEFALA K, Ponvert C
    Allergic contact dermatitis to chlorhexidine-containing antiseptics and their excipients in children: A series of six cases.
    Pediatr Dermatol. 2022 Dec 13. doi: 10.1111/pde.15127.
    PubMed     Abstract available

    November 2022
  49. GILLOW G, Jackson K, Mukherji J, Buranosky B, et al
    Timing of scratch and limb movements during sleep in children with atopic dermatitis.
    Pediatr Dermatol. 2022 Nov 29. doi: 10.1111/pde.15212.
    PubMed     Abstract available

  50. ANAND P, Schneeweiss S, Mostaghimi A, Schneeweiss MC, et al
    Longitudinal utilization of systemic immunomodulators before and after dupilumab approval in children with atopic dermatitis.
    Pediatr Dermatol. 2022 Nov 20. doi: 10.1111/pde.15172.
    PubMed     Abstract available

  51. RICCIARDO BM, Kessaris HL, Kumarasinghe P, Carapetis JR, et al
    The burden of atopic dermatitis and bacterial skin infections among urban-living Indigenous children and young people in high-income countries: A systematic review.
    Pediatr Dermatol. 2022 Nov 9. doi: 10.1111/pde.15153.
    PubMed     Abstract available

  52. CASTELLI B, Marrani E, Fusco E, Chiara C, et al
    Adjunctive treatment with infliximab in pediatric immunoglobulin A (IgA) vasculitis: A case report.
    Pediatr Dermatol. 2022;39:946-949.
    PubMed     Abstract available

  53. SETHOMO W, Williams VL, Tladi P, Gabaitiri L, et al
    Skin conditions among pediatric dermatology outpatients in Botswana.
    Pediatr Dermatol. 2022;39:883-888.
    PubMed     Abstract available

  54. NIHAL A, Comstock JR, Holland KE, Singh AM, et al
    Clearance of atypical cutaneous manifestations of hyper-IgE syndrome with dupilumab.
    Pediatr Dermatol. 2022;39:940-942.
    PubMed     Abstract available

  55. SHEU SONG J, Huang JT, Fraile Alonso MDC, Antaya RJ, et al
    Toxic epidermal necrolysis-like acute graft-versus-host disease in pediatric bone marrow transplant patients: Case series and review of the literature.
    Pediatr Dermatol. 2022;39:889-895.
    PubMed     Abstract available

  56. IRIARTE C, Karim SA, Nassim JS, Grenier PO, et al
    Infantile Stevens Johnson syndrome and toxic epidermal necrolysis: A systematic review of clinical features and outcomes in children ages 12 months and under.
    Pediatr Dermatol. 2022;39:876-882.
    PubMed     Abstract available

    October 2022
  57. LARIJANI M, Zarowin D, Wohlschlaeger A, Perman MJ, et al
    Atopic dermatitis-like graft-versus-host disease treated with dupilumab.
    Pediatr Dermatol. 2022 Oct 21. doi: 10.1111/pde.15146.
    PubMed     Abstract available

  58. CHEN HW, Limmer EE, Joseph AK, Kinser K, et al
    Efficacy of a lay community health worker (promotoras de salud) program to improve adherence to emollients in Spanish-speaking Latin American pediatric patients in the United States with atopic dermatitis: A randomized, controlled, evaluator-blinded s
    Pediatr Dermatol. 2022 Oct 20. doi: 10.1111/pde.15148.
    PubMed     Abstract available

  59. LABIB A, Golpanian RS, Aickara D, Smith P, et al
    The effect of fatty acids, vitamins, and minerals on pediatric atopic dermatitis: A systematic review.
    Pediatr Dermatol. 2022 Oct 20. doi: 10.1111/pde.15143.
    PubMed     Abstract available

    September 2022
  60. MCPHERSON T, Cork MJ, Goodhead C, Michaelis LJ, et al
    A real-world retrospective observational study exploring NHS resource use in England for the management of moderate-to-severe atopic dermatitis in secondary care for children and adolescents.
    Pediatr Dermatol. 2022 Sep 20. doi: 10.1111/pde.15134.
    PubMed     Abstract available

  61. ITURRIAGA C, Bustos MF, Le Roy C, Rodriguez R, et al
    Association between obesity and atopic dermatitis in children: A case-control study in a high obesity prevalence population.
    Pediatr Dermatol. 2022 Sep 1. doi: 10.1111/pde.15110.
    PubMed     Abstract available

  62. SHI JQ, Dong XS, Zhang LL, Liu ZH, et al
    Herpes simplex virus encephalitis in atopic dermatitis patients and responses to dupilumab: A real association or a chance occurrence?
    Pediatr Dermatol. 2022;39:848-849.

  63. BEZIRGANOGLU H, Arik Yilmaz E, Sahiner UM, Soyer O, et al
    The common triggers of urticaria in children admitted to the pediatric emergency room.
    Pediatr Dermatol. 2022;39:695-701.
    PubMed     Abstract available

    August 2022
  64. ALEXOPOULOS A, Dakoutrou M, Nasi L, Thanopoulou I, et al
    A randomized, observer-blind, vehicle-control, multi-center clinical investigation for assessing the efficacy and tolerability of a 1% ectoine and hyaluronic acid 0.1%-containing medical device in pediatric patients with mild-to-moderate atopic dermat
    Pediatr Dermatol. 2022 Aug 29. doi: 10.1111/pde.15117.
    PubMed     Abstract available

  65. ZHENG DX, Cwalina TB, Mulligan KM, Gallo Marin B, et al
    Delayed medical care due to transportation barriers among US children with atopic dermatitis.
    Pediatr Dermatol. 2022 Aug 25. doi: 10.1111/pde.15124.
    PubMed     Abstract available

  66. SCOLLAN ME, Garzon MC, Lauren CT
    State medicaid coverage of over-the-counter moisturizers: A cost-effective management strategy for atopic dermatitis?
    Pediatr Dermatol. 2022 Aug 12. doi: 10.1111/pde.15038.
    PubMed     Abstract available

    July 2022
  67. O'CONNOR C, Livingstone V, Hourihane JOB, Irvine AD, et al
    Parental atopy and risk of atopic dermatitis in the first two years of life in the BASELINE birth cohort study.
    Pediatr Dermatol. 2022 Jul 25. doi: 10.1111/pde.15090.
    PubMed     Abstract available

  68. NGUYEN SM, Lee M, Lin W, Ngo JV, et al
    Blisters in a 7-year-old girl with atopic dermatitis.
    Pediatr Dermatol. 2022 Jul 13. doi: 10.1111/pde.15039.

  69. SIRIPIPATTANAMONGKOL N, Rattanasak S, Taiyaitieng C, Inthajak Y, et al
    Toxic epidermal necrolysis after first dose of Pfizer-BioNTech (BNT162b2) vaccination with pharmacogenomic testing.
    Pediatr Dermatol. 2022;39:601-605.
    PubMed     Abstract available

    Comment on "Toxic epidermal necrolysis (TEN) after first dose of Pfizer (BNT162b2) vaccination and pharmacogenomic-based-point-care support: First case report in pediatric and review of literature".
    Pediatr Dermatol. 2022;39:671-672.

    May 2022
  71. MAZZONI D, Lobo Y, Levitt D, Wheller L, et al
    Severe atopic dermatitis in a 21-month-old boy successfully treated with dupilumab.
    Pediatr Dermatol. 2022 May 16. doi: 10.1111/pde.14996.
    PubMed     Abstract available

  72. SARVER MM, Quow K, Prose NS
    Atopic dermatitis leading to failure to thrive: A case report.
    Pediatr Dermatol. 2022 May 16. doi: 10.1111/pde.14983.
    PubMed     Abstract available

  73. CROCE EA, Rathouz PJ, Lopes FCPS, Leszczynska M, et al
    Validation of remote atopic dermatitis severity assessment with the Eczema Area and Severity Ondex in children using caregiver-provided photos and videos.
    Pediatr Dermatol. 2022 May 6. doi: 10.1111/pde.15003.
    PubMed     Abstract available

  74. THOMPSON AM, Seivright J, Hsiao JL, Shi VY, et al
    Bibliometric analysis of the 50 most cited publications in atopic dermatitis.
    Pediatr Dermatol. 2022 May 5. doi: 10.1111/pde.15027.
    PubMed     Abstract available

  75. ALJUNDI N, Utz Petry S, Moossavi M, Daveluy S, et al
    Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms following nivolumab and ipilimumab in a pediatric patient with melanoma.
    Pediatr Dermatol. 2022;39:486-487.
    PubMed     Abstract available

  76. ZALADONIS CA, Safeer LZ, Smith D, Hafeez F, et al
    Intralesional corticosteroid injections to treat lip swelling associated with oral Crohn's disease in a child.
    Pediatr Dermatol. 2022;39:506-508.
    PubMed     Abstract available

  77. CARMONA-CRUZ SA, Duran-McKinster LC, Garcia-Romero MT
    Atypical purpura and other features associated with unfavorable outcomes of IgA vasculitis (Henoch-Schonlein purpura) in children: A retrospective study.
    Pediatr Dermatol. 2022;39:369-371.
    PubMed     Abstract available

    March 2022
  78. DUPUY E, Afifi L, Jonas SJ, Cheng CE, et al
    A Case of severe mosquito bite allergy complicated by fatal hemophagocytic lymphohistiocytosis.
    Pediatr Dermatol. 2022 Mar 23. doi: 10.1111/pde.14877.
    PubMed     Abstract available

  79. RAMIREZ-MARIN HA, Silverberg JI
    Differences between pediatric and adult atopic dermatitis.
    Pediatr Dermatol. 2022 Mar 16. doi: 10.1111/pde.14971.
    PubMed     Abstract available

  80. RAO M, Grove D, Haggstrom A
    A rare presentation of herpes simplex virus encephalitis occurring in a pediatric patient on dupilumab for atopic dermatitis.
    Pediatr Dermatol. 2022 Mar 3. doi: 10.1111/pde.14970.
    PubMed     Abstract available

  81. HAVELE SA, Khurana MC, McMahon P, Murthy AS, et al
    Safety of dupilumab in a 5-month-old infant with severe atopic dermatitis.
    Pediatr Dermatol. 2022;39:291-294.
    PubMed     Abstract available

  82. ZHONG LS, Huang BQ, Tang WT, Zhuo ZQ, et al
    Bullous impetigo-like irritant contact dermatitis caused by perfume.
    Pediatr Dermatol. 2022;39:320-321.
    PubMed     Abstract available

    February 2022
  83. JOSEPH AK, Chen HW, Hassan Youssef S, Limmer EE, et al
    Evaluating the impact of a community health worker (Promotora de Salud) program on attitudes and beliefs regarding atopic dermatitis among Spanish-speaking Latin-American caregivers.
    Pediatr Dermatol. 2022 Feb 17. doi: 10.1111/pde.14917.
    PubMed     Abstract available

  84. CUNNINGHAM EP, Carter NF
    Tinea incognito "mask"erading as allergic contact dermatitis due to COVID-19 facial covering in children.
    Pediatr Dermatol. 2022 Feb 4. doi: 10.1111/pde.14911.
    PubMed     Abstract available

    January 2022
  85. PALLER AS, Beck LA, Blauvelt A, Siegfried EC, et al
    Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data.
    Pediatr Dermatol. 2022 Jan 26. doi: 10.1111/pde.14909.
    PubMed     Abstract available

  86. PARK HH, Haft MA, Burdick EA, Boiko S, et al
    Creating patient-directed education in pediatric dermatology: A guide for creators.
    Pediatr Dermatol. 2022;39:155-161.
    PubMed     Abstract available

  87. LEE EY, Wee CLP, Tan CH, Wee LWY, et al
    Pediatric patch testing in a multi-ethnic Asian population: A retrospective review.
    Pediatr Dermatol. 2022;39:69-76.
    PubMed     Abstract available

    December 2021
  88. ZHOU NY, Nili A, Blackwell CK, Ogbuefi N, et al
    Parent report of sleep health and attention regulation in a cross-sectional study of infants and preschool-aged children with atopic dermatitis.
    Pediatr Dermatol. 2021 Dec 21. doi: 10.1111/pde.14889.
    PubMed     Abstract available

    November 2021
  89. ASINIWASIS RN, Heck E, Amir Ali A, Ogunyemi B, et al
    Atopic dermatitis and skin infections are a poorly documented crisis in Canada's Indigenous pediatric population: It's time to start the conversation.
    Pediatr Dermatol. 2021;38 Suppl 2:188-189.
    PubMed     Abstract available

  90. Dupilumab for atopic dermatitis.
    Pediatr Dermatol. 2021;38:1559-1560.

  91. GRAYSON C, Heath C
    Tips for addressing common conditions affecting pediatric and adolescent patients with skin of color.
    Pediatr Dermatol. 2021;38 Suppl 2:155-157.
    PubMed     Abstract available

    October 2021
  92. PARKER JJ, Sugarman JL, Silverberg NB, Gonzalez ME, et al
    Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children.
    Pediatr Dermatol. 2021 Oct 14. doi: 10.1111/pde.14820.
    PubMed     Abstract available

    September 2021
  93. ERTUGRUL A, Baskaya N, Cetin S, Bostanci I, et al
    Anaphylaxis and epinephrine autoinjector use in pediatric patients with cutaneous mastocytosis.
    Pediatr Dermatol. 2021 Sep 24. doi: 10.1111/pde.14800.
    PubMed     Abstract available

  94. BROOKS BE, Bercovitch L
    Closing the knowledge gaps in pediatric emergency department management of atopic dermatitis flares: Responding to the challenge.
    Pediatr Dermatol. 2021;38:1404-1405.

  95. BERREBI D, Farmer W, Zinn Z
    BASCULE syndrome in a child with prior asymptomatic COVID-19 infection.
    Pediatr Dermatol. 2021;38:1342-1344.
    PubMed     Abstract available

  96. SHETH AP, Vivar KL, Wagner AM, Kruse LL, et al
    Henoch Schonlein purpura in pediatric patients with inflammatory bowel disease: A case series.
    Pediatr Dermatol. 2021;38:1389-1392.
    PubMed     Abstract available

  97. UGWU N, Cheraghlou S, Antaya RJ, Feng H, et al
    Trends in office visits and treatment for urticaria in children in the United States, 1998-2016.
    Pediatr Dermatol. 2021;38:1162-1168.
    PubMed     Abstract available

  98. JACKSON-COWAN L, Cole EF, Arbiser JL, Silverberg JI, et al
    TH2 sensitization in the skin-gut-brain axis: How early-life Th2-mediated inflammation may negatively perpetuate developmental and psychologic abnormalities.
    Pediatr Dermatol. 2021;38:1032-1039.
    PubMed     Abstract available

  99. MAHER MC, Hall EM, Horii KA
    Generalized eczematous dermatitis and pruritus responsive to dupilumab in a patient with immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.
    Pediatr Dermatol. 2021;38:1370-1371.
    PubMed     Abstract available

  100. KING D, Roberts K, Stenton S, Jenkins A, et al
    Stevens-Johnson syndrome associated with Hodgkin's lymphoma.
    Pediatr Dermatol. 2021;38:1347-1348.
    PubMed     Abstract available

  101. EL HASBANI G, Taher AT, Jawad ASM, Uthman I, et al
    Henoch-Schonlein purpura: Another COVID-19 complication.
    Pediatr Dermatol. 2021;38:1359-1360.
    PubMed     Abstract available

  102. O'BRIAN M, Kolitz E, Jeong HS, Cao L, et al
    A severe presentation of acute generalized exanthematous pustulosis with non-infectious circulatory shock in an adolescent.
    Pediatr Dermatol. 2021;38:1267-1271.
    PubMed     Abstract available

  103. NAMBA T, Ebuchi Y, Manabe K, Shimizu J, et al
    Infantile leukocytoclastic vasculitis caused by enterotoxin-producing methicillin-sensitive Staphylococcus aureus.
    Pediatr Dermatol. 2021;38:1288-1291.
    PubMed     Abstract available

  104. KAPLAN F, Topal E
    Acute generalized exanthematous pustulosis due to Epstein-Barr virus infection in a neonate.
    Pediatr Dermatol. 2021;38:1354-1356.
    PubMed     Abstract available

  105. DAUGHERTY LN, Spraker MK, Lawley LP
    Neonate with migratory annular erythematous patches.
    Pediatr Dermatol. 2021;38:1320-1321.

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge.